Concurrent treatment of aplastic anemia/paroxysmal nocturnal hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience

Haematologica. 2018 Aug;103(8):e345-e347. doi: 10.3324/haematol.2017.183046. Epub 2018 Mar 15.

Affiliations

¹ Hematology department, St James University Hospital, Leeds, London, UK m.griffin@nhs.net.
² Hematology department, King's college University Hospital, London, UK.
³ Hematology department, St James University Hospital, Leeds, London, UK.

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Anemia, Aplastic / drug therapy*
Antibodies, Monoclonal, Humanized / therapeutic use*
Case-Control Studies
Child
Female
Hemoglobinuria, Paroxysmal / drug therapy*
Humans
Immunosuppression Therapy / methods*
Male
Middle Aged
Retrospective Studies
Treatment Outcome
United Kingdom
Young Adult

Substances

Antibodies, Monoclonal, Humanized
eculizumab